IAP086IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study

Sponsor:

University of North Carolina, Chapel Hill

Code:

NCT07596888

Conditions

HIV-1-infection

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Accepted

Interventions

IAP086 0.3 mcg/kg

IAP086 1 mcg/kg

IAP086 3 mcg/kg

IAP086 6 mcg/kg

IAP086 10 mcg/kg

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-28. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2026-08-17.